Scisparc Ltd
SPRC
View Detailed Chart
1.460USD
-0.060-3.95%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
780.52KMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-3.95%
5 Days
-20.65%
1 Month
-40.65%
6 Months
-76.71%
Year to Date
-80.69%
1 Year
-67.47%
View Detailed Chart
TradingKey Stock Score of Scisparc Ltd
Currency: USD Updated: 2025-10-27Key Insights
Its valuation is considered fairly valued, Institutional ownership is relatively high.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Scisparc Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Scisparc Ltd Highlights
StrengthsRisks
Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
Growing
The company is in a growing phase, with the latest annual income totaling USD 1.31M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.31M.
Fairly Valued
The company’s latest PE is -2.28, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 8.04K shares, increasing 12.09% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 2.07K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of -0.65.
Scisparc Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Scisparc Ltd Info
Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
Ticker SymbolSPRC
CompanyScisparc Ltd
CEOWeiss (Amitay)
Websitehttps://scisparc.com/
FAQs
What is the current price of Scisparc Ltd (SPRC)?
The current price of Scisparc Ltd (SPRC) is 1.460.
What is the symbol of Scisparc Ltd?
The ticker symbol of Scisparc Ltd is SPRC.
What is the 52-week high of Scisparc Ltd?
The 52-week high of Scisparc Ltd is 37.590.
What is the 52-week low of Scisparc Ltd?
The 52-week low of Scisparc Ltd is 1.550.
What is the market capitalization of Scisparc Ltd?
The market capitalization of Scisparc Ltd is 780.52K.
What is the net income of Scisparc Ltd?
The net income of Scisparc Ltd is -6.28M.
Is Scisparc Ltd (SPRC) currently rated as Buy, Hold, or Sell?
According to analysts, Scisparc Ltd (SPRC) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of Scisparc Ltd (SPRC)?
The Earnings Per Share (EPS TTM) of Scisparc Ltd (SPRC) is -1.663.
Related Instruments
+1.32%
-0.88%
+1.75%
+0.83%
+0.60%
+0.38%
+0.91%
+1.03%
+2.32%
+0.60%
+0.40%
+1.97%
+1.63%
+1.21%
+0.65%
+0.66%
+2.57%
0.00%
-0.44%
+1.06%
